$PACS Balance Sheet | Understand Stock

$PACS

$47.85 -$0.91 (1.87%) Close

$PACS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2024 As of Sep 30, 2024	Q1 FY2025 As of Mar 31, 2025	Q2 FY2025 As of Jun 30, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2025 As of Sep 30, 2025	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024
ASSETS
Current Assets:
Cash and cash equivalents
Accounts receivable, net
Other receivables
Prepaid expenses and other current assets
Total Current Assets
Property and equipment, net
Operating lease right-of-use assets
Insurance subsidiary deposits and investments
Escrow funds
Goodwill and other indefinite-lived assets
Other assets
Total Assets
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable
Accrued payroll and benefits
Current operating lease liabilities
Current maturities of long-term debt
Current portion of accrued self-insurance liabilities
Current line of credit
Refund liability
Other accrued expenses
Total Current Liabilities
Long-term operating lease liabilities
Accrued benefits, less current portion
Line of credit
Long-term debt, less current maturities, net of deferred financing fees
Accrued self-insurance liabilities, less current portion
Other liabilities
Total Liabilities
Equity:
Common stock: $0.001 par value; 1,250,000,000 shares authorized; 158,335,612 shares issued and outstanding as of June 30, 2026, and 156,615,144 shares issued and outstanding as of December 31, 2025
Accumulated other comprehensive income
Additional paid-in capital
Retained earnings
Total PACS Group, Inc. stockholders' equity
Noncontrolling interest in subsidiary
Total Equity
Total Liabilities and Equity

Comments